Ozempic, Wegovy and Mounjaro are among the weight-loss drugs that more people are taking - but questions have been raised about their economic impacts.
These drugs will also have an impact on other sectors, including healthcare and food, and research is still ongoing.
Fisher Funds expert Sam Dickie explained further.
LISTEN ABOVE

Nick Sautner: Eden Park CEO responds to mayor Wayne Brown's comments on events funding
04:21

Enda Brady: UK correspondent on Wes Streeting reportedly challenging Starmer for leadership
04:30

Jamie Mackay: The Country host on the CEO of Synlait resigning
03:42